Dr. Badawy is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 East Chicago Avenue
Box #30
Chicago, IL 60611Phone+1 312-227-4836
Education & Training
- McGaw Medical Center of Northwestern UniversityFellowship, Pediatric Hematology/Oncology, 2016
- Zagazig University Faculty of MedicineClass of 2005
Certifications & Licensure
- IL State Medical License 2016 - 2026
- WI State Medical License 2013 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease Start of enrollment: 2020 Sep 28
Roles: Principal Investigator
- The Longitudinal Relationship of HU Adherence to HRQOL, Barriers to Adherence and Habit in SCD. Start of enrollment: 2021 Mar 02
Roles: Principal Investigator
- Applying Directly Observed Therapy to Hydroxyurea to Realize Effectiveness Start of enrollment: 2024 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- Digital cognitive behavioral therapy vs education for pain in adults with sickle cell disease.Charles R Jonassaint, Christina M Lalama, C Patrick Carroll, Sherif M Badawy, Megan E Hamm
Blood Advances. 2024-12-24 - The prevalence of opioid misuse diagnostic codes in children with sickle cell disease.Ann-Marie Tantoco, Sherif M Badawy, Cheryl K Lee, Jeffrey Merz, Maura Steed
Pediatric Hematology and Oncology. 2024-12-11 - 1 citationsRates of severe neutropenia and infection risk in patients treated with deferiprone: 28 years of data.Sherif M Badawy, Jan Palmblad, Fernando Tricta, Noemi Toiber Temin, Caroline Fradette
Blood Advances. 2024-11-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: